⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1926113 | 0.88 | — | — | |
| SCHEMBL472871 | 0.87 | — | — | |
| SCHEMBL27444047 | 0.85 | — | — | |
| SCHEMBL27858829 | 0.85 | — | — | |
| Hydrochloric Acid SCHEMBL11048878 | 0.85 | — | — | |
| SCHEMBL1862443 | 0.85 | — | — | |
| Benzene SCHEMBL28446162 | 0.82 | — | — | |
| Methylamine SCHEMBL27476913 | 0.82 | — | — | |
| Ethylene SCHEMBL27304002 | 0.82 | — | — | |
| Propane SCHEMBL28563778 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230355625-A1 | METHODS OF TREATMENT | INTRA-CELLULAR THERAPIES, INC. | 2023-11-09 | — | — | US | claimed |
| WO-2023173131-A2 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. (US) | 2023-09-14 | — | — | WO | claimed |
| EP-4188353-A1 | NOVEL USES | Intra-Cellular Therapies, Inc. (US) | 2023-06-07 | — | — | EP | claimed |
| US-20230071934-A1 | NOVEL USES | INTRA-CELLULAR THERAPIES, INC. | 2023-03-09 | — | — | US | claimed |
| US-20220354851-A1 | METHODS OF TREATMENT | INTRA-CELLULAR THERAPIES, INC. | 2022-11-10 | — | — | US | claimed |
| EP-4065573-A1 | METHODS OF TREATMENT | Intra-Cellular Therapies, Inc. (US) | 2022-10-05 | — | — | EP | claimed |
| US-20220280517-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. (US) | 2022-09-08 | — | — | US | claimed |
| EP-4025218-A1 | METHODS OF TREATMENT | Intra-Cellular Therapies, Inc. (US) | 2022-07-13 | — | — | EP | claimed |
| EP-4017858-A1 | ORGANIC COMPOUNDS | Intra-Cellular Therapies, Inc. (US) | 2022-06-29 | — | — | EP | claimed |
| WO-2022026417-A1 | NOVEL USES | INTRA-CELLULAR THERAPIES, INC. (US) | 2022-02-03 | — | — | WO | claimed |
| US-20110237561-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. | 2011-09-29 | — | — | US | claimed |
| EP-2367428-A1 | ORGANIC COMPOUNDS | Intra-Cellular Therapies, Inc. (US) | 2011-09-28 | — | — | EP | claimed |
| WO-2010132127-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. (US) | 2010-11-18 | — | — | WO | claimed |
| US-20100273753-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. | 2010-10-28 | — | — | US | claimed |
| US-20100273754-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. | 2010-10-28 | — | — | US | claimed |
| EP-2240028-A1 | ORGANIC COMPOUNDS | Intra-Cellular Therapies, Inc. (US) | 2010-10-20 | — | — | EP | claimed |
| EP-2240490-A1 | ORGANIC COMPOUNDS | Intra-Cellular Therapies, Inc. (US) | 2010-10-20 | — | — | EP | claimed |
| WO-2010065147-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. (US) | 2010-06-10 | — | — | WO | claimed |
| WO-2009075784-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. (US) | 2009-06-18 | — | — | WO | claimed |
| WO-2009073210-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC (US) | 2009-06-11 | — | — | WO | claimed |